XIAFLEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

What this means for you

Registered since 12 Oct 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Oct 2020).

Record

Serial number

77883942

Registration number

3862018

Mark type

Design + words

Filed

02 Dec 2009

Published for opposition

18 May 2010

Registered

12 Oct 2010

Next maintenance due

12 Oct 2020

Attorney of record

Camille M. Miller

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, collagenase enzyme used to treat fibroproliferative disease conditions such as Dupuytren's contracture, Peyronie's disease and Frozen Shoulder Syndrome also known as Adhesive Capsulitis

Owner

• ENDO BIOLOGICS LIMITED, BALLSBRIDGE, IE
• ENDO GLOBAL VENTURES, HAMILTON, BM
• AUXILIUM BERMUDA UNLIMITED, HAMILTON, BM
• Auxilium US Holdings, LLC., Wilmington, DE, US
• Auxilium US Holdings, LLC., Wilmington, DE, US
• Auxilium US Holdings, LLC., Wilmington, DE, US

Prosecution history

• 28 Jun 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 01 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 22 Sept 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 03 Jun 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 21 Nov 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 21 Nov 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 21 Nov 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 21 Nov 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 14 Oct 2019 — TEAS SECTION 8 & 9 RECEIVED
• 12 Oct 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 10 Aug 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 04 Dec 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 04 Dec 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 04 Dec 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 12 Oct 2015 — TEAS SECTION 8 & 15 RECEIVED